Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease

A. Limsuwan; P. Pienvichit; P. Khowsathit

doi:10.1007/s00246-005-0925-4

Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease

A. Limsuwan
, P. Pienvichit
, P. Khowsathit

Ramathibodi Hospital

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Abstract

We present a report on children with severe pulmonary hypertension secondary to congenital heart disease who received 6 months of beraprost therapy. The children had an increase in intracardiac left-to-right shunt and a reduction of the pulmonary-to-systemic vascular resistance ratio, whereas the pulmonary artery pressure was not significantly changed.

Original language	English
Pages (from-to)	787-791
Number of pages	5
Journal	Pediatric Cardiology
Volume	26
Issue number	6
DOIs	https://doi.org/10.1007/s00246-005-0925-4
Publication status	Published - Dec 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Congenital heart disease
Eisenmenger syndrome
Pulmonary hypertension

Access to Document

10.1007/s00246-005-0925-4

Cite this

@article{74587434b2854fe7a61e0e018d219a4a,

title = "Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease",

abstract = "We present a report on children with severe pulmonary hypertension secondary to congenital heart disease who received 6 months of beraprost therapy. The children had an increase in intracardiac left-to-right shunt and a reduction of the pulmonary-to-systemic vascular resistance ratio, whereas the pulmonary artery pressure was not significantly changed.",

keywords = "Congenital heart disease, Eisenmenger syndrome, Pulmonary hypertension",

author = "A. Limsuwan and P. Pienvichit and P. Khowsathit",

year = "2005",

month = dec,

doi = "10.1007/s00246-005-0925-4",

language = "English",

volume = "26",

pages = "787--791",

journal = "Pediatric Cardiology",

issn = "0172-0643",

publisher = "Springer",

number = "6",

}

TY - JOUR

T1 - Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease

AU - Limsuwan, A.

AU - Pienvichit, P.

AU - Khowsathit, P.

PY - 2005/12

Y1 - 2005/12

N2 - We present a report on children with severe pulmonary hypertension secondary to congenital heart disease who received 6 months of beraprost therapy. The children had an increase in intracardiac left-to-right shunt and a reduction of the pulmonary-to-systemic vascular resistance ratio, whereas the pulmonary artery pressure was not significantly changed.

AB - We present a report on children with severe pulmonary hypertension secondary to congenital heart disease who received 6 months of beraprost therapy. The children had an increase in intracardiac left-to-right shunt and a reduction of the pulmonary-to-systemic vascular resistance ratio, whereas the pulmonary artery pressure was not significantly changed.

KW - Congenital heart disease

KW - Eisenmenger syndrome

KW - Pulmonary hypertension

UR - https://www.scopus.com/pages/publications/31144458147

U2 - 10.1007/s00246-005-0925-4

DO - 10.1007/s00246-005-0925-4

M3 - Article

C2 - 16132278

AN - SCOPUS:31144458147

SN - 0172-0643

VL - 26

SP - 787

EP - 791

JO - Pediatric Cardiology

JF - Pediatric Cardiology

IS - 6

ER -

Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this